The functional dlt operon of Clostridium butyricum controls the d-alanylation of cell wall components and influences cell septation and vancomycin-induced lysis

Anaerobe

Volumn 35, Issue , 2015, Pages 105-114

  Wydau Dematteis, Sandra ^a   Louis, Mathilde ^a   Zahr, Noël ^b   Lai Kuen, René ^c   Saubaméa, Bruno ^c   Butel, Marie José ^a   Pons, Jean Louis ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c CNRS   (France)

Author keywords

Antimicrobial peptides; Cell wall; Clostridium butyricum; Complemented strain; DltD mutant; Septation

Indexed keywords

LYSOZYME; VANCOMYCIN; ALANINE; ANTIINFECTIVE AGENT; TEICHOIC ACID;

ARTICLE; BACTERIAL GROWTH; CELL COMPONENT; CELL FUNCTION; CELL SEPTATION; CELL SURFACE; CELL WALL; CLOSTRIDIUM BUTYRICUM; CONTROLLED STUDY; DLT GENE; GENE; GENETIC CODE; LYSIS; NONHUMAN; OPERON; PRIORITY JOURNAL; SURFACE PROPERTY; BACTERIOLYSIS; CELL DIVISION; DRUG EFFECTS; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROSCOPY;

ALANINE; ANTI-BACTERIAL AGENTS; BACTERIOLYSIS; CELL DIVISION; CELL WALL; CLOSTRIDIUM BUTYRICUM; MICROSCOPY; OPERON; SURFACE PROPERTIES; TEICHOIC ACIDS; VANCOMYCIN;

EID: 84941931765     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2015.09.001     Document Type: Article

References (57)

1. Howard F.M., Flynn D.M., Bradley J.M., Noone P., Szawatkowski M. Outbreak of necrotising enterocolitis caused by Clostridium butyricum. Lancet 1977, 2:1099-1102.
2. Smith B., Bode S., Petersen B.L., Jensen T.K., Pipper C., Kloppenborg J., Boye M., Krogfelt K.A., Molbak L. Community analysis of bacteria colonizing intestinal tissue of neonates with necrotizing enterocolitis. BMC Microbiol. 2011, 11:73.
3. Sturm R., Staneck J.L., Stauffer L.R., Neblett W.W. Neonatal necrotizing enterocolitis associated with penicillin-resistant, toxigenic Clostridium butyricum. Pediatrics 1980, 66:928-931.
4. Waligora-Dupriet A.J., Dugay A., Auzeil N., Huerre M., Butel M.J. Evidence for clostridial implication in necrotizing enterocolitis through bacterial fermentation in a gnotobiotic quail model. Pediatr. Res. 2005, 58:629-635.
5. Ferraris L., Butel M.J., Campeotto F., Vodovar M., Roze J.C., Aires J. Clostridia in premature neonates' gut: incidence, antibiotic susceptibility, and perinatal determinants influencing colonization. PLoS One 2012, 7:e30594.
6. Gudmundsson G.H., Agerberth B. Neutrophil antibacterial peptides, multifunctional effector molecules in the mammalian immune system. J. Immunol. Methods 1999, 232:45-54.
7. Muller C.A., Autenrieth I.B., Peschel A. Innate defenses of the intestinal epithelial barrier. Cell Mol. Life Sci. 2005, 62:1297-1307.
8. Nizet V. Antimicrobial peptide resistance mechanisms of human bacterial pathogens. Curr. Issues Mol. Biol. 2006, 8:11-26.
9. Peschel A. How do bacteria resist human antimicrobial peptides?. Trends Microbiol. 2002, 10:179-186.
10. Neuhaus F.C., Baddiley J. A continuum of anionic charge: structures and functions of D-alanyl-teichoic acids in gram-positive bacteria. Microbiol. Mol. Biol. Rev. 2003, 67:686-723.
11. Reichmann N.T., Cassona C.P., Grundling A. Revised mechanism of D-alanine incorporation into cell wall polymers in Gram-positive bacteria. Microbiology 2013, 159:1868-1877.
12. Fisher N., Shetron-Rama L., Herring-Palmer A., Heffernan B., Bergman N., Hanna P. The dltABCD operon of Bacillus anthracis sterne is required for virulence and resistance to peptide, enzymatic, and cellular mediators of innate immunity. J. Bacteriol. 2006, 188:1301-1309.
13. Abachin E., Poyart C., Pellegrini E., Milohanic E., Fiedler F., Berche P., Trieu-Cuot P. Formation of D-alanyl-lipoteichoic acid is required for adhesion and virulence of Listeria monocytogenes. Mol. Microbiol. 2002, 43:1-14.
14. Wartha F., Beiter K., Albiger B., Fernebro J., Zychlinsky A., Normark S., Henriques-Normark B. Capsule and D-alanylated lipoteichoic acids protect Streptococcus pneumoniae against neutrophil extracellular traps. Cell Microbiol. 2007, 9:1162-1171.
15. Weidenmaier C., Peschel A., Kempf V.A., Lucindo N., Yeaman M.R., Bayer A.S. DltABCD- and MprF-mediated cell envelope modifications of Staphylococcus aureus confer resistance to platelet microbicidal proteins and contribute to virulence in a rabbit endocarditis model. Infect. Immun. 2005, 73:8033-8038.
16. Saar-Dover R., Bitler A., Nezer R., Shmuel-Galia L., Firon A., Shimoni E., Trieu-Cuot P., Shai Y. D-alanylation of lipoteichoic acids confers resistance to cationic peptides in group B streptococcus by increasing the cell wall density. PLoS Pathog. 2012, 8:e1002891.
17. Poyart C., Pellegrini E., Marceau M., Baptista M., Jaubert F., Lamy M.C., Trieu-Cuot P. Attenuated virulence of Streptococcus agalactiae deficient in D-alanyl-lipoteichoic acid is due to an increased susceptibility to defensins and phagocytic cells. Mol. Microbiol. 2003, 49:1615-1625.
18. Molnar J., Pragai B. Attempts to detect the presence of teichoic acid in Bacillus anthracis. Acta Microbiol. Acad. Sci. Hung. 1971, 18:105-108.
19. Read T.D., Peterson S.N., Tourasse N., Baillie L.W., Paulsen I.T., Nelson K.E., Tettelin H., Fouts D.E., Eisen J.A., Gill S.R., Holtzapple E.K., Okstad O.A., Helgason E., Rilstone J., Wu M., Kolonay J.F., Beanan M.J., Dodson R.J., Brinkac L.M., Gwinn M., DeBoy R.T., Madpu R., Daugherty S.C., Durkin A.S., Haft D.H., Nelson W.C., Peterson J.D., Pop M., Khouri H.M., Radune D., Benton J.L., Mahamoud Y., Jiang L., Hance I.R., Weidman J.F., Berry K.J., Plaut R.D., Wolf A.M., Watkins K.L., Nierman W.C., Hazen A., Cline R., Redmond C., Thwaite J.E., White O., Salzberg S.L., Thomason B., Friedlander A.M., Koehler T.M., Hanna P.C., Kolsto A.B., Fraser C.M. The genome sequence of Bacillus anthracis Ames and comparison to closely related bacteria. Nature 2003, 423:81-86.
20. Reid C.W., Vinogradov E., Li J., Jarrell H.C., Logan S.M., Brisson J.R. Structural characterization of surface glycans from Clostridium difficile. Carbohydr. Res. 2012, 354:65-73.
21. McBride S.M., Sonenshein A.L. The dlt operon confers resistance to cationic antimicrobial peptides in Clostridium difficile. Microbiology 2011, 157:1457-1465.
22. Bousseboua H., Le C.Y., Dabard J., Szylit O., Raibaud P., Popoff M.R., Ravisse P. Experimental cecitis in gnotobiotic quails monoassociated with Clostridium butyricum strains isolated from patients with neonatal necrotizing enterocolitis and from healthy newborns. Infect. Immun. 1989, 57:932-936.
23. Novick R. Properties of a cryptic high-frequency transducing phage in Staphylococcus aureus. Virology 1967, 33:155-166.
24. Hussain H.A., Roberts A.P., Mullany P. Generation of an erythromycin-sensitive derivative of Clostridium difficile strain 630 (630Deltaerm) and demonstration that the conjugative transposon Tn916DeltaE enters the genome of this strain at multiple sites. J. Med. Microbiol. 2005, 54:137-141.
25. Trieu-Cuot P., Arthur M., Courvalin P. Origin, evolution and dissemination of antibiotic resistance genes. Microbiol. Sci. 1987, 4:263-266.
26. Heap J.T., Kuehne S.A., Ehsaan M., Cartman S.T., Cooksley C.M., Scott J.C., Minton N.P. The ClosTron: mutagenesis in Clostridium refined and streamlined. J. Microbiol. Methods 2010, 80:49-55.
27. Heap J.T., Pennington O.J., Cartman S.T., Carter G.P., Minton N.P. The ClosTron: a universal gene knock-out system for the genus Clostridium. J. Microbiol. Methods 2007, 70:452-464.
28. Miyauchi E., Morita M., Rossi M., Morita H., Suzuki T., Tanabe S. Effect of D-alanine in teichoic acid from the Streptococcus thermophilus cell wall on the barrier-protection of intestinal epithelial cells. Biosci. Biotechnol. Biochem. 2012, 76:283-288.
29. Pan W.H., Li P.L., Liu Z. The correlation between surface hydrophobicity and adherence of Bifidobacterium strains from centenarians' faeces. Anaerobe 2006, 12:148-152.
30. El Meouche I., Peltier J., Monot M., Soutourina O., Pestel-Caron M., Dupuy B., Pons J.L. Characterization of the SigD regulon of C. difficile and its positive control of toxin production through the regulation of tcdR. PLoS One 2013, 8:e83748.
31. Herbert S., Bera A., Nerz C., Kraus D., Peschel A., Goerke C., Meehl M., Cheung A., Gotz F. Molecular basis of resistance to muramidase and cationic antimicrobial peptide activity of lysozyme in staphylococci. PLoS Pathog. 2007, 3:e102.
32. Perego M., Glaser P., Minutello A., Strauch M.A., Leopold K., Fischer W. Incorporation of D-alanine into lipoteichoic acid and wall teichoic acid in Bacillus subtilis. Identification of genes and regulation. J. Biol. Chem. 1995, 270:15598-15606.
33. Peschel A., Otto M., Jack R.W., Kalbacher H., Jung G., Gotz F. Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J. Biol. Chem. 1999, 274:8405-8410.
34. Peschel A., Vuong C., Otto M., Gotz F. The D-alanine residues of Staphylococcus aureus teichoic acids alter the susceptibility to vancomycin and the activity of autolytic enzymes. Antimicrob. Agents Chemother. 2000, 44:2845-2847.
35. Perea V.M., Verhoeven T.L., Draing C., Von A.S., Pfitzenmaier M., Geyer A., Lambrichts I., Grangette C., Pot B., Vanderleyden J., De Keersmaecker S.C. Functional analysis of D-alanylation of lipoteichoic acid in the probiotic strain Lactobacillus rhamnosus GG. Appl. Environ. Microbiol. 2007, 73:3595-3604.
36. Steen A., Palumbo E., Deghorain M., Cocconcelli P.S., Delcour J., Kuipers O.P., Kok J., Buist G., Hols P. Autolysis of Lactococcus lactis is increased upon D-alanine depletion of peptidoglycan and lipoteichoic acids. J. Bacteriol. 2005, 187:114-124.
37. Wecke J., Perego M., Fischer W. D-alanine deprivation of Bacillus subtilis teichoic acids is without effect on cell growth and morphology but affects the autolytic activity. Microb. Drug Resist. 1996, 2:123-129.
38. Daniel R.A., Errington J. Control of cell morphogenesis in bacteria: two distinct ways to make a rod-shaped cell. Cell 2003, 113:767-776.
39. Kramer N.E., Hasper H.E., van den Bogaard P.T., Morath S., de K.B., Hartung T., Smid E.J., Breukink E., Kok J., Kuipers O.P. Increased D-alanylation of lipoteichoic acid and a thickened septum are main determinants in the nisin resistance mechanism of Lactococcus lactis. Microbiology 2008, 154:1755-1762.
40. Brown S., Santa Maria J.P.J., Walker S. Wall teichoic acids of gram-positive bacteria. Annu. Rev. Microbiol. 2013, 67:313-336.
41. Schneewind O., Missiakas D. Lipoteichoic acids, phosphate-containing polymers in the envelope of gram-positive bacteria. J. Bacteriol. 2014, 196:1133-1142.
42. Cai G., Jin B., Saint C., Monis P. Genetic manipulation of butyrate formation pathways in Clostridium butyricum. J. Biotechnol. 2011, 155:269-274.
43. Cai G., Jin B., Monis P., Saint C. A genetic and metabolic approach to redirection of biochemical pathways of Clostridium butyricum for enhancing hydrogen production. Biotechnol. Bioeng. 2013, 110:338-342.
44. Fabretti F., Theilacker C., Baldassarri L., Kaczynski Z., Kropec A., Holst O., Huebner J. Alanine esters of enterococcal lipoteichoic acid play a role in biofilm formation and resistance to antimicrobial peptides. Infect. Immun. 2006, 74:4164-4171.
45. Kristian S.A., Datta V., Weidenmaier C., Kansal R., Fedtke I., Peschel A., Gallo R.L., Nizet V. D-alanylation of teichoic acids promotes group a streptococcus antimicrobial peptide resistance, neutrophil survival, and epithelial cell invasion. J. Bacteriol. 2005, 187:6719-6725.
46. Biswas R., Martinez R.E., Gohring N., Schlag M., Josten M., Xia G., Hegler F., Gekeler C., Gleske A.K., Gotz F., Sahl H.G., Kappler A., Peschel A. Proton-binding capacity of Staphylococcus aureus wall teichoic acid and its role in controlling autolysin activity. PLoS One 2012, 7:e41415.
47. Camiade E., Peltier J., Bourgeois I., Couture-Tosi E., Courtin P., Antunes A., Chapot-Chartier M.P., Dupuy B., Pons J.L. Characterization of Acp, a peptidoglycan hydrolase of Clostridium perfringens with N-acetylglucosaminidase activity that is implicated in cell separation and stress-induced autolysis. J. Bacteriol. 2010, 192:2373-2384.
48. Giaouris E., Briandet R., Meyrand M., Courtin P., Chapot-Chartier M.P. Variations in the degree of D-Alanylation of teichoic acids in Lactococcus lactis alter resistance to cationic antimicrobials but have no effect on bacterial surface hydrophobicity and charge. Appl. Environ. Microbiol. 2008, 74:4764-4767.
49. Bera A., Biswas R., Herbert S., Kulauzovic E., Weidenmaier C., Peschel A., Gotz F. Influence of wall teichoic acid on lysozyme resistance in Staphylococcus aureus. J. Bacteriol. 2007, 189:280-283.
50. During K., Porsch P., Mahn A., Brinkmann O., Gieffers W. The non-enzymatic microbicidal activity of lysozymes. FEBS Lett. 1999, 449:93-100.
51. Ibrahim H.R., Matsuzaki T., Aoki T. Genetic evidence that antibacterial activity of lysozyme is independent of its catalytic function. FEBS Lett. 2001, 506:27-32.
52. Ibrahim H.R., Thomas U., Pellegrini A. A helix-loop-helix peptide at the upper lip of the active site cleft of lysozyme confers potent antimicrobial activity with membrane permeabilization action. J. Biol. Chem. 2001, 276:43767-43774.
53. Laible N.J., Germaine G.R. Bactericidal activity of human lysozyme, muramidase-inactive lysozyme, and cationic polypeptides against Streptococcus sanguis and Streptococcus faecalis: inhibition by chitin oligosaccharides. Infect. Immun. 1985, 48:720-728.
54. Ferraris L., Butel M.J., Aires J. Antimicrobial susceptibility and resistance determinants of Clostridium butyricum isolates from preterm infants. Int. J. Antimicrob. Agents 2010, 36:420-423.
55. Magot M. Some properties of the Clostridium butyricum group beta-lactamase. J. Gen. Microbiol. 1981, 127:113-119.
56. Bravetti A.L., Mesnage S., Lefort A., Chau F., Eckert C., Garry L., Arthur M., Fantin B. Contribution of the autolysin AtlA to the bactericidal activity of amoxicillin against Enterococcus faecalis JH2-2. Antimicrob. Agents Chemother. 2009, 53:1667-1669.
57. Gazzola S., Cocconcelli P.S. Vancomycin heteroresistance and biofilm formation in Staphylococcus epidermidis from food. Microbiology 2008, 154:3224-3231.